Vutrisiran-impurities | Pharmaffiliates

Vutrisiran

Vutrisiran, sold under the brand name Amvuttra, is a medication used for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis. Reference standards of Vutrisiran API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Vutrisiran - API Standards 
    [catalogue_number] => PA 22 1030000
    [category_ids] => ,76,78,70,82,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 1867157-35-4
    [pslug] => 1867157-35-4-vutrisiran-api-pa221030000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 22 1030000

Vutrisiran - API Standards


  • Catalogue No.:PA 22 1030000

  • CAS :

    1867157-35-4

  • Molecular Formula : NA

  • Molecular Weight : NA